Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
J&J Investors Call For Global Talcum Powder Recall In Face of Ovarian Cancer and Asbestos ConcernsThe proposal would force Johnson & Johnson to hold a shareholder vote on whether it should continue talcum powder sales worldwide. February 8, 2022 Irvin Jackson Add Your CommentsFollowing years of concerns about a link between talcum powder and ovarian cancer, and tens of thousands of lawsuits filed against Johnson & Johnson for failing to warn adult women about the risks associated with applying talc-based Baby Powder, a group of investors are pushing to force the company to finally issue a global talcum powder recall.The activist investment group Tulipshare has submitted a proposal that calls for Johnson & Johnson to remove talc-based products from store shelves worldwide. The group is trying to force a shareholder vote on the issue, and has submitted a proposal to the Security and Exchange Commission (SEC).Tulipshare hopes the SEC will greenlight the proposal and require the vote and Johnson & Johnsonโs next annual meeting, which is likely to be held in April.Johnson & Johnson currently faces more than 30,000ย Baby Powder lawsuitsย andย Shower-to-Shower lawsuitsย brought throughout the U.S. court system, each involving similar allegations that talc and asbestos particles in the products caused women to develop ovarian cancer, mesothelioma and other injuries.Learn More AboutTalcum Powder LawsuitsTalcum powder or talc powder may cause women to develop ovarian cancer.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONLearn More AboutTalcum Powder LawsuitsTalcum powder or talc powder may cause women to develop ovarian cancer.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONJohnson & Johnson has already pulled talc powder products from store shelves in the United States and Canada. However, it is still widely available in the rest of the world, including Europe and the U.K.โJohnson & Johnsonโs talc-based Baby Powder (talcum powder) was shown to contain traces of asbestos โ a carcinogen known to cause cancer with no safe exposure level,โ Tulipshare wrote. โWhatโs worse is that Johnson & Johnson reportedly knew about the asbestos contamination, yet continued to heavily market the product to minority, overweight women.โIn December, Johnson & Johnson wrote a letter (PDF) to the SEC asking that it reject the Tulipshare proposal, saying that such a decision would interfere with the ongoing litigation. The proposal was originally submitted in October.The SEC has yet to render a decision.The call for the shareholder vote over a potential global talcum powder recall comes after Johnson & Johnson announced in October that it is attempting to spin off any liability exposure it faces from the lawsuits into a new company, LTL Management, LLC, which was formed for the express purpose of placing the new unit into bankruptcy. The move has been widely criticized, since Johnson & Johnson has billions of assets on hand, and the bankruptcy scheme has been viewed largely as a negotiating ploy to force plaintiffs to accept less compensation than they seek.Theย Johnson & Johnson talcum powder bankruptcy planย has been successful in delaying progress in the litigation, allowing the company to avoid a series of trials that were expected to go before juries this year. However, plaintiffs lawyers and bankruptcy experts are strenuously opposing the plan, and calling for the judge presiding over the matter to reject the filing, indicating that it is an abuse of the U.S. bankruptcy process.Defending against the talcum powder litigation has cost Johnson & Johnson $1 billion, on top of settlements and verdicts that have amounted to another $3.5 billion, according to the bankruptcy filing. However, it is widely expected that any talcum powder settlements will require well over $15 billion to avoid thousands of individual cases going before juries nationwide. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Asbestos, Baby Powder, Bankruptcy, Cancer, Investors, Johnson & Johnson, Ovarian Cancer, Shower to Shower, Talcum PowderMore Talcum Powder Lawsuit Stories J&J Agrees to $5.5B Talcum Powder Settlement Payout to Resolve Ovarian Cancer Lawsuits July 29, 2026 Additional Talks To Settle Talcum Powder Cancer Lawsuits Set for April 13 March 20, 2026 Ovarian Cancer Talcum Powder Lawsuit Results in $250K Verdict Against J&J February 16, 2026 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: today)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026) Neurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (Posted: yesterday)A womanโs lawsuit claims prolonged use of gabapentin to treat nerve pain resulted in significant memory problems, cognitive decline and early-onset dementia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITGabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026) FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk (Posted: 2 days ago)Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.MORE ABOUT: OZEMPIC LAWSUITOzempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (10/30/2026)GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: today)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
Neurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (Posted: yesterday)A womanโs lawsuit claims prolonged use of gabapentin to treat nerve pain resulted in significant memory problems, cognitive decline and early-onset dementia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITGabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk (Posted: 2 days ago)Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.MORE ABOUT: OZEMPIC LAWSUITOzempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (10/30/2026)GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)